Tesamorelin 10mg + Ipamorelin 3mg

Peptide Profile

Tesa (Tesamorelin) + IPA (Ipamorelin) combines two advanced growth-hormone–related peptides frequently studied for their synergistic impact on body-composition, lipid metabolism, and cellular regeneration.

Tesamorelin, a stabilized analogue of Growth Hormone–Releasing Hormone (GHRH), is recognized in research for its targeted action on lipolytic and metabolic signaling pathways. It is often used to explore mechanisms involved in fat metabolism, lipid mobilization, and growth hormone pulse regulation.

Ipamorelin (IPA), a selective Growth Hormone Secretagogue (GHS), complements Tesamorelin by promoting smooth and consistent GH release without significant stimulation of other endocrine pathways. This makes the combination ideal for investigating fat-to-energy conversion, cellular repair signaling, and tissue-recovery responses associated with GH and IGF-1 activity.

Researchers value this dual formulation for its precision and versatility in studies exploring body-composition modulation, mitochondrial support, and regenerative pathways that may influence metabolic performance.

Key Highlights

• Dual-mechanism peptide pairing: Tesamorelin (GHRH analogue) + Ipamorelin (GHS)
• Investigated for fat metabolism, body-composition balance, and regenerative signaling
• High-purity, lab-grade formulation verified for molecular stability and accuracy
• Manufactured under stringent quality and purity control standards
• For laboratory research use only